The Hybridization of Multi-Walled Carbon Nanotubes with Various Drugs

Adriana Duma Voiculet; Mariana Prodana; Ioana Demetrescu

doi:10.4028/www.scientific.net/KEM.638.85

Paper Titles

Hydroxyapatite Coating Influenced by Ti6Al4V Substrate Roughness
p.62

Mesenchymal Stem Cell Response to Surface Altered Porous Ti
p.67

New Flexible Cyanoacrylate Tissue Adhesive Adhflex^®: Adhesion and Performance in Inguinal Hernia Repair
p.73

XRD and Microstructural Analyses on Biodegradable Mg Alloys
p.79

The Hybridization of Multi-Walled Carbon Nanotubes with Various Drugs
p.85

Structural Analysis of the Laser Welding Co-Cr-Mo-(Ti) Alloys for Removable Partial Dentures
p.91

Three-Dimensional Nanostructures with Biocidal Activity Created on a Siloxane-Containing Copolyimide Film
p.98

Effect of Calcium Content on the Microstructure and Degradation of Mg-Ca Binary Alloys Potentially Used as Orthopedic Biomaterials
p.104

Cooling Conditions Influence on Cortical Bovine Bones Derived Hydroxyapatite
p.111

HomeKey Engineering MaterialsKey Engineering Materials Vol. 638The Hybridization of Multi-Walled Carbon Nanotubes...

The Hybridization of Multi-Walled Carbon Nanotubes with Various Drugs

Abstract:

Functionalized multiwalled carbon nanotubes (MWCNTs) by various groups (carboxyl or amino) can improve the properties of anti-tumoral drugs (cisplatin, docetaxel, zometa). Functionalization was evidenced by infrared spectroscopy (FTIR) and transmission electron microscopy (TEM). Platinum ions released in simulated body fluid (SBF) were measured by inductively coupled plasma ion spectrometry (ICP-MS).

You might also be interested in these eBooks

View Preview

Info:

Periodical:

Key Engineering Materials (Volume 638)

Pages:

85-90

DOI:

https://doi.org/10.4028/www.scientific.net/KEM.638.85

Citation:

Cite this paper

Online since:

March 2015

Authors:

Adriana Duma Voiculet, Mariana Prodana*, Ioana Demetrescu

Keywords:

Carbon Nanotube (CN), Drug, FTIR, Functionalization, TEM

Export:

RIS, BibTeX

Price:

Permissions CCC:

Request Permissions

Permissions PLS:

Request Permissions

Сopyright:

Citation:

* - Corresponding Author

References

[1] B. W Stewart and P. Kleihuers, World Cancer Report, WHO, (2003).

Google Scholar

[2] J.R. Kanwar, G. Mahidhara and R.K. Kanwar, Foundation review: Antiangiogenic therapy using nanotechnological-based delivery system, Drug. Discov. Today. 16 ( 2011) 188-202.

DOI: 10.1016/j.drudis.2011.01.007

Google Scholar

[3] J. Y Chen , L. S Shen Foo Recalcitrant Hyperkalaemia Associated with a Single Dose Administration of Zoledronic Acid for Treatment of Post-Menopausal Osteoporosis, Chen, J Osteopor Phys Act, 1(2) (2013) 1-3.

DOI: 10.4172/2329-9509.1000105

Google Scholar

[4] J. Zekri, M. Mansour, M. S Karim, The anti-tumour effects of zoledronic acid, J. Bone. Oncol. 3 (2014) 25-35.

DOI: 10.1016/j.jbo.2013.12.001

Google Scholar

[5] P. Parhi, C. Mohanty, S.K. Sahoo Nanotechology-based combinational drug delivery: an emerging approach for cancer therapy, Drug Discov Today, 17(17-18) (2012) 1044-1052.

DOI: 10.1016/j.drudis.2012.05.010

Google Scholar

[6] A. Duma (Voiculet), M. Prodana, I. Demetrescu, Cisplatin functionalization of multiwalld carbon nanotubes, U.P.B. Sci. Bull. B, 76(1) ( 2014) 49-58.

Google Scholar

[7] M. Prodana, A. Voiculet, S. Garea, M. Radu, H Iovu, I Demetrescu, A Dinischiotu Synthesis, characterization and controlled toxicity of a novel hybrid material based on cisplatin and docetaxel" Cent. Eur. J. Chem., 12(10) (2014) 1008-1015.

DOI: 10.2478/s11532-014-0536-0

Google Scholar

[8] H. He, Pham-Huy LA, Dramou P., Xiao D, Zuo P, Pham-Huy C, Carbon nanotubes: applications in pharmacy and medicine, Biomed. Res. Int. (2013) 578290.

DOI: 10.1155/2013/578290

Google Scholar